4Wouters KA, Kremer LC, Miller TL, et al. Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies[J]. Br J Haematol, 2005,131(5) :561 - 578.
5Hong YM, Kim HS, Yoon HR. Serum lipid and fatty acid profiles in adriamvcin-treated rats after administration of L-carnitine[J].Pediatr Res, 2002, 51(2):249-255.
6Lipshultz SE. Exposure to anthracyclines during childhood causes cardiac injury[J]. Semin Oncol, 2006,33(3 Suppl 8) :8 - 14.
8Elliott P. Pathogenesis of cardiotoxicity induced by anthracyclines[J]. Semin Oncol, 2006,33 (3 Suppl 8) : S2 -S7.
9Iwanaga Y, Nishi I, Furuiehi S, et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart fail ure: comparison between systolic and diastolic heart failure[J].J Am Coil Cardiol, 2006, 47 (4) : 742 - 748.
10Mir TS, Marohn S,Laer S, et al. Plasma concentrations of N-tenninal pro-brain natriuretie peptide in control children from the neonatal to adolescent period and in children witb congestive heart failure [J]. Pediatrics, 2002, 110 (6) : e76.
